Three most undervalued biotech stocks to buy now will take off in the coming years and bring back continuous, hefty returns. More
Articles
Why You Shouldn’t “Sell in May and Go Away”
The reality is there’s an interesting phenomenon in play right now that’s expected to help small- and mid-cap stocks in the coming months. So, in today’s Market 360, we’ll go over why I think this year will be the summer of small-cap stocks. More